STUDY OBJECTIVE: Mycoplasma genitalium (MG) is a sexually transmitted pathogen linked to female morbidity, but testing for MG is not standardized. We aimed to determine which point-of-care (POC) vaginal tests could predict MG infection. DESIGN, SETTING, PARTICIPANTS: A cross sectional study recruited sexually active adolescent women, aged 14-22 y (n = 217) from an urban medical center. INTERVENTIONS AND MAIN OUTCOME MEASURES: Vaginal swabs were POC tested for pH, amines, clue cells, sialidase, and Trichomonas vaginalis (TV). MG was detected by research-use-only transcription mediated amplification (TMA) assay. Presence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) were confirmed using TMA. Three criteria were required for diagnosis of clinical BV: pH > 4.5, presence of amines, and >20% clue cells. Associations were assessed using logistic regression (LR). RESULTS: TMA detected MG in 30 (14%), CT in 49 (23%), and NG in 21 (10%) of the samples tested. POC vaginal tests were positive for TV in 21%, amines in 52%, clue cells in 33%, sialidase in 22%, pH > 4.5 in 56%, and clinical BV in 19% of the samples tested. Using LR, pH > 4.5 was a predictor of MG (odds ratio 4.4, P < .05). Of 131 women without clinical BV or TV, 25% of those with pH > 4.5 had MG, compared to 9% of those with pH ≤ 4.5 (P = .02). CONCLUSIONS: Until standardized, approved testing for MG is available, pH may be a useful indicator to suspect MG, especially in the absence of BV and TV.
STUDY OBJECTIVE:Mycoplasma genitalium (MG) is a sexually transmitted pathogen linked to female morbidity, but testing for MG is not standardized. We aimed to determine which point-of-care (POC) vaginal tests could predict MG infection. DESIGN, SETTING, PARTICIPANTS: A cross sectional study recruited sexually active adolescent women, aged 14-22 y (n = 217) from an urban medical center. INTERVENTIONS AND MAIN OUTCOME MEASURES: Vaginal swabs were POC tested for pH, amines, clue cells, sialidase, and Trichomonas vaginalis (TV). MG was detected by research-use-only transcription mediated amplification (TMA) assay. Presence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) were confirmed using TMA. Three criteria were required for diagnosis of clinical BV: pH > 4.5, presence of amines, and >20% clue cells. Associations were assessed using logistic regression (LR). RESULTS:TMA detected MG in 30 (14%), CT in 49 (23%), and NG in 21 (10%) of the samples tested. POC vaginal tests were positive for TV in 21%, amines in 52%, clue cells in 33%, sialidase in 22%, pH > 4.5 in 56%, and clinical BV in 19% of the samples tested. Using LR, pH > 4.5 was a predictor of MG (odds ratio 4.4, P < .05). Of 131 women without clinical BV or TV, 25% of those with pH > 4.5 had MG, compared to 9% of those with pH ≤ 4.5 (P = .02). CONCLUSIONS: Until standardized, approved testing for MG is available, pH may be a useful indicator to suspect MG, especially in the absence of BV and TV.
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: J Clin Epidemiol Date: 2008-04 Impact factor: 6.437
Authors: Beverley A Lawton; Sally B Rose; Collette Bromhead; Louise A Gaitanos; E Jane MacDonald; Kim A Lund Journal: Contraception Date: 2008-03-04 Impact factor: 3.375
Authors: Jill S Huppert; Joel E Mortensen; Jennifer L Reed; Jessica A Kahn; Kimberly D Rich; Marcia M Hobbs Journal: Sex Transm Dis Date: 2008-03 Impact factor: 2.830
Authors: Aneesh K Tosh; Barbara Van Der Pol; J Dennis Fortenberry; James A Williams; Barry P Katz; Byron E Batteiger; Donald P Orr Journal: J Adolesc Health Date: 2007-02-15 Impact factor: 5.012
Authors: V L Short; P A Totten; R B Ness; S G Astete; S F Kelsey; P Murray; C L Haggerty Journal: Sex Transm Infect Date: 2009-08-24 Impact factor: 3.519
Authors: Gwendolyn E Wood; Dorothy L Patton; Peter K Cummings; Stefanie L Iverson-Cabral; Patricia A Totten Journal: Infect Immun Date: 2017-01-26 Impact factor: 3.441
Authors: Sally N Adebamowo; Eileen O Dareng; Ayotunde O Famooto; Richard Offiong; Olayinka Olaniyan; Kayode Obende; Amos Adebayo; Sanni Ologun; Bunmi Alabi; Peter Achara; Rasheed A Bakare; Michael Odutola; Oluwatoyosi Olawande; James Okuma; George Odonye; Ruxton Adebiyi; Patrick Dakum; Clement A Adebamowo Journal: Int J Epidemiol Date: 2017-12-01 Impact factor: 7.196
Authors: Kristen R Moore; Meena Tomar; Brandie D Taylor; Scott E Gygax; David W Hilbert; Donna D Baird Journal: Sex Transm Dis Date: 2021-02-01 Impact factor: 3.868
Authors: A García-Galán; C De la Fe; J Gomis; E Bataller; A Sánchez; J J Quereda; E García-Roselló; A Gómez-Martín Journal: BMC Vet Res Date: 2020-07-20 Impact factor: 2.741